Delta-3-Carene: Pine-Scented Terpene, Thin Evidence, One Persistent Myth

Delta-3-carene smells like a freshly cut pine board with something sweet behind it. It is the terpene that gives Indian and Scandinavian turpentine their character, and in cannabis it is usually a background note behind pinene. Online it has acquired a reputation it did not earn: the terpene that “dries out” your mouth and eyes. This profile sets out what delta-3-carene is, what the handful of studies on it found, and where that reputation came from.

What is delta-3-carene?

Delta-3-carene (also written 3-carene or Δ³-carene) is a bicyclic monoterpene: ten carbons, like pinene and limonene, folded into a six-membered ring fused to a three-membered one. That strained cyclopropane ring is unusual among common cannabis terpenes. Delta-3-carene also autoxidizes readily in air, producing compounds that matter for the safety section below. For the family tree, see the language behind terpenes.

Its home is turpentine. Some Indian turpentines contain up to about 70 percent delta-3-carene, and Finnish and Swedish turpentines are also carene-rich, though usually less so. Portuguese turpentine has been measured at under 1 percent, and French turpentine, from maritime pine, is almost entirely alpha- and beta-pinene, which helps explain why oils sold under the same name can differ substantially in composition and odor. [1,2] In cannabis it is a minor player. In a 2020 compilation of published terpene profiles, delta-3-carene made the ten most abundant terpenes in 7 of 108 chemotypes and was never the dominant one; it did not reach the top ten in any of the 54 flower samples. [3] When a certificate of analysis lists it at all, it is usually a small fraction of the terpene total, well behind pinene, which it accompanies in both pine resin and cannabis.

What does it smell like, and where does it turn up?

Sweet, resinous and sharp: pine needles first, then something closer to damp wood and musk. Its reported boiling point is about 170 °C. That is useful analytical information, but it does not predict precisely when carene will leave a complex cannabis matrix in a vaporizer. Like other monoterpenes it is volatile, so handling and storage can change the concentration eventually measured. In a cannabis terpene profile it tends to travel with the pinenes, and cultivars described as “piney” usually owe more to alpha-pinene than to carene. Its distinctive note is easier to pick out in a fresh mango, where it is among the major headspace volatiles and may contribute to its resinous, pine-like notes, than in most flower. [4]

Laboratories measure it the way they measure the rest of the monoterpenes, by gas chromatography, and many commercial terpene panels include it. Two practical notes for reading a certificate. First, carene is volatile enough that the number depends on when the sample was taken: a profile run at harvest and one run after months on a shelf are measuring different flower. Second, the oxidation chemistry described below applies to the sample vial as much as to a bottle of terpenes, which is one reason analytical labs keep terpene standards cold and under inert gas. For how terpene analysis is done and what its uncertainties are, see how labs test for terpenes.

What does the evidence say about inflammation?

The anti-inflammatory claim rests on two 1989 papers from Granada on the essential oil of Bupleurum gibraltaricum, a Mediterranean relative of the carrot. The first found that the whole oil reduced carrageenan-induced paw swelling in rats and altered the contraction of isolated rat uterus, and the authors suggested the effect was “due to the delta-3-carene component.” [5] The second compared oils from different stands of the plant and reported that the one richest in delta-3-carene was the most active against acute inflammation. [6]

That is an attribution, not a demonstration. The oil was a mixture; its carene content varied alongside everything else in it; and the uterine experiments, where pure carene was compared with the oil, were about smooth muscle, not inflammation. We have made this mistake on this site before, crediting an oil’s effect to the one ingredient someone was interested in, and it was the error in the 2019 version of this page. No study we could find has tested purified delta-3-carene in an inflammation model in animals or people. The honest statement is that a carene-rich oil was anti-inflammatory in rats in 1989, and nobody has followed up.

What does the evidence say about bone?

One paper. In a 2008 screen of 89 natural compounds, delta-3-carene at low micromolar concentrations increased alkaline phosphatase activity in a mouse osteoblast cell line by day 9 and increased calcium deposition by day 15, with changes in MAP-kinase signaling and in transcripts for osteopontin and type I collagen. [7] The authors closed by suggesting that dietary essential oils containing carene might benefit bone health. That is a hypothesis from a dish of mouse cells. There is no animal bone study and no human study, and the step from a cell line to a skeleton is the one that most compounds never make.

Does delta-3-carene help with sleep?

This is the best-designed study on the terpene and still a mouse study. In 2019 a Korean group gave mice delta-3-carene by mouth at 12.5 to 100 mg/kg before a pentobarbital challenge; at the top dose the mice fell asleep faster and slept longer, to a degree the authors compared with zolpidem at 10 mg/kg. In brain-slice recordings carene lengthened the decay of inhibitory synaptic currents, and flumazenil, which blocks the benzodiazepine site on the GABA-A receptor, abolished the effect. [8] So there is a plausible mechanism, and it is the same one that makes benzodiazepines sedating.

Two things keep this from being a sleep claim for cannabis. The dose: 100 mg/kg by mouth in a mouse is, allowing for the usual body-surface scaling, something on the order of half a gram of pure carene for an adult, whereas a gram of flower that is 1 percent terpenes by weight, with carene making up 2 percent of those terpenes, holds a fifth of a milligram, much of which is lost in the smoke. Those are illustrative numbers, but the gap is three orders of magnitude. And the model: pentobarbital-induced sleep in mice is a screen for sedative activity, not a measure of sleep quality. No human has been given carene to study sleep.

Does delta-3-carene dry out your mouth and eyes?

This is the claim that follows carene around the internet: that it “dries excess body fluids,” causes cottonmouth and red eyes, and has an anticholinergic or antihistamine action. We went looking for its source. Two separate searches of the pharmacology literature found no study, in any species, in which delta-3-carene reduced salivary, lacrimal or mucous secretion, and no paper describing it as anticholinergic. The consumer sites that repeat the claim either cite nothing or cite each other, and at least one describes the reports as anecdotal.

The nearest thing to a primary source is a sentence in the 1989 Granada paper noting that carene, like the whole oil, shifted the response of isolated rat uterus to acetylcholine. [5] That is a smooth-muscle observation, not a gland, and it would be a long road from there to cottonmouth. A much better-supported explanation involves cannabinoid receptors in the salivary glands. Activating those receptors reduced saliva flow in rats, while CB1 and CB2 blockers reversed the effect. [9] That provides a plausible cannabinoid-mediated mechanism for cannabis dry mouth; no comparable evidence implicates delta-3-carene. Our own terpene guide repeated the drying claim for years; we are correcting it there too.

What is the firm human finding?

The clearest human evidence concerns irritation and contact allergy, not benefit. The sensitizers are air-oxidation products, hydroperoxides that form when terpenes sit exposed to oxygen. French occupational guidance notes that the turpentines richest in delta-3-carene are the most sensitizing, while alpha-pinene and other constituents are also often implicated. [2] Carene sensitized 15 of 22 guinea pigs in one test. [1] In a 1990s outbreak among pottery decorators, which followed a switch from Portuguese to carene-richer Indonesian turpentine, 14 of 24 affected workers reacted to the Indonesian turpentine, eight to alpha-pinene and four to delta-3-carene; going back to Portuguese turpentine appeared to ease the problem. [10]

Irritation is a separate question from allergy. In patch tests on people who were not allergic to turpentine, freshly distilled terpenes irritated skin at 70 to 80 percent strength but not at 20 to 35 percent; once oxidized to a hydroperoxide content above about 2 percent, they irritated most of the people tested. [1] In a chamber study, healthy volunteers who breathed carene vapor for two hours at 10, 225 and 450 mg/m³ reported significantly more irritation only at the highest level. [11]

None of this is a reason to fear the small amount of carene in flower. It is a reason to handle concentrated terpene blends carefully: follow the supplier’s storage instructions, keep containers cool, dark and tightly sealed, and avoid putting concentrated terpenes directly on the skin. Limonene, pinene and terpinene can also form more sensitizing products as they oxidize.

Where does that leave the “trifecta”?

The 2019 version of this page called delta-3-carene the trifecta terpene for inflammation, bone and sleep. On the evidence: inflammation is an unsupported attribution from a whole-oil study; bone is one mouse cell-line paper; sleep is one mouse study at a dose no joint will deliver. The drying claim has no source at all. What delta-3-carene reliably does is smell of pine, co-occur with pinene, and contribute to skin allergy once it has oxidized. If any of its proposed effects is going to matter in cannabis, it would need to be tested at realistic cannabis exposures, both alone and in mixtures; our entourage effect review sets out how little of that testing has been done. For the rest of the family, start at the terpene education hub.

References

1. National Industrial Chemicals Notification and Assessment Scheme (Australia). Turpentine: human health tier II assessment. June 29, 2018.
2. Institut national de recherche et de sécurité (INRS). Essence de térébenthine. Fiche toxicologique no. 132. Paris: INRS; May 2024 edition.
3. Hanuš LO, Hod Y. Terpenes/terpenoids in cannabis: are they important? Medical Cannabis and Cannabinoids. 2020;3:25–60.
4. Salazar Sandoval I, Santiesteban Hernández A, Velásquez Valdez G, et al. Volatiles of mango var. Ataulfo characterized by SPME and capillary GC/MS spectroscopy. Journal of the Mexican Chemical Society. 2007;51(3).
5. Ocete MA, Risco S, Zarzuelo A, Jimenez J. Pharmacological activity of the essential oil of Bupleurum gibraltaricum: anti-inflammatory activity and effects on isolated rat uteri. Journal of Ethnopharmacology. 1989;25(3):305–313.
6. Gil ML, Jimenez J, Ocete MA, et al. Comparative study of different essential oils of Bupleurum gibraltaricum Lamarck. Die Pharmazie. 1989;44(4):284–287.
7. Jeong JG, et al. Low concentration of 3-carene stimulates the differentiation of mouse osteoblastic MC3T3-E1 subclone 4 cells. Phytotherapy Research. 2008;22(1):18–22.
8. Woo J, Yang H, Yoon M, et al. 3-Carene, a phytoncide from pine tree has a sleep-enhancing effect by targeting the GABA-A-benzodiazepine receptors. Experimental Neurobiology. 2019;28(5):593–601.
9. Prestifilippo JP, Fernández-Solari J, de la Cal C, et al. Inhibition of salivary secretion by activation of cannabinoid receptors. Experimental Biology and Medicine. 2006;231(8):1421–1429.
10. Lear JT, Heagerty AHM, Tan BB, et al. Transient re-emergence of oil of turpentine allergy in the pottery industry. Contact Dermatitis. 1996;35(3):169–172.
11. Falk A, et al. Human exposure to 3-carene by inhalation: toxicokinetics, effects on pulmonary function and occurrence of irritative and CNS symptoms. Toxicology and Applied Pharmacology. 1991;110(2):198–205.

Originally published November 26, 2019. Rebuilt October 2026: the three 2019 claims re-examined against their sources, the whole-oil attribution corrected, the drying claim traced, and the human sensitization data added.